全文获取类型
收费全文 | 1558432篇 |
免费 | 110510篇 |
国内免费 | 2906篇 |
专业分类
耳鼻咽喉 | 21613篇 |
儿科学 | 45640篇 |
妇产科学 | 39034篇 |
基础医学 | 231198篇 |
口腔科学 | 45593篇 |
临床医学 | 138487篇 |
内科学 | 300201篇 |
皮肤病学 | 34375篇 |
神经病学 | 116860篇 |
特种医学 | 60190篇 |
外国民族医学 | 151篇 |
外科学 | 241684篇 |
综合类 | 31528篇 |
现状与发展 | 3篇 |
一般理论 | 397篇 |
预防医学 | 109061篇 |
眼科学 | 36572篇 |
药学 | 120654篇 |
42篇 | |
中国医学 | 4634篇 |
肿瘤学 | 93931篇 |
出版年
2021年 | 11795篇 |
2018年 | 16666篇 |
2017年 | 12988篇 |
2016年 | 14835篇 |
2015年 | 16914篇 |
2014年 | 22796篇 |
2013年 | 33158篇 |
2012年 | 44778篇 |
2011年 | 46765篇 |
2010年 | 27765篇 |
2009年 | 26059篇 |
2008年 | 43802篇 |
2007年 | 46156篇 |
2006年 | 47065篇 |
2005年 | 44658篇 |
2004年 | 43095篇 |
2003年 | 41022篇 |
2002年 | 40095篇 |
2001年 | 82524篇 |
2000年 | 84637篇 |
1999年 | 70380篇 |
1998年 | 17498篇 |
1997年 | 15237篇 |
1996年 | 15490篇 |
1995年 | 14610篇 |
1994年 | 13481篇 |
1993年 | 12431篇 |
1992年 | 53725篇 |
1991年 | 52452篇 |
1990年 | 50639篇 |
1989年 | 49695篇 |
1988年 | 45224篇 |
1987年 | 44060篇 |
1986年 | 41444篇 |
1985年 | 39374篇 |
1984年 | 28494篇 |
1983年 | 24208篇 |
1982年 | 12970篇 |
1979年 | 25624篇 |
1978年 | 17632篇 |
1977年 | 15028篇 |
1976年 | 13710篇 |
1975年 | 15044篇 |
1974年 | 18019篇 |
1973年 | 17176篇 |
1972年 | 16222篇 |
1971年 | 15208篇 |
1970年 | 14578篇 |
1969年 | 13581篇 |
1968年 | 12439篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Proton pump inhibitors are associated with accelerated development of cirrhosis,hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES 下载免费PDF全文
D. K. Li P. Yan A‐B. Abou‐Samra R. T. Chung A. A. Butt 《Alimentary pharmacology & therapeutics》2018,47(2):246-258
82.
83.
Sofosbuvir and velpatasvir with or without voxilaprevir in direct‐acting antiviral‐naïve chronic hepatitis C: patient‐reported outcomes from POLARIS 2 and 3 下载免费PDF全文
84.
85.
Serum pepsinogen 1 and anti‐Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males 下载免费PDF全文
86.
Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension 下载免费PDF全文
87.
88.
89.
Javariya Aamir Syed Mustafa Ali Maged N. Kamel Boulos Naveed Anjum Muhammad Ishaq 《Health Policy and Technology》2018,7(1):88-97
Objective
The objective of this review is to identify enabling and inhibiting factors for mHealth adoption in low resource settings, by giving emphasis on the stakeholders representing the caregiving side. Another objective of this study is to support implementation agencies (governmental and non-governmental) in designing scalable mHealth interventions.Methods
A PEO (Population, Exposure, Outcome) approach was used to formulate the review question. A pre-defined search strategy was implemented; Google Scholar, PubMed and gray literature were searched using alternate terms for “mHealth”, “adoption” and “developing countries”. CASP [7] tools were used to assess the quality of selected evidence. After applying inclusion and exclusion criteria on search results and critical appraisal of the selected evidence, twelve studies were selected for the review.Results
Adoption factors operated at the levels of organization, facility-based service provider and frontline health worker. Engagement of end users during design phase, informed clinical decision making, utilization of mHealth evidence, employers’ tolerance of some personal use of devices, automation of tasks and user-friendliness of application are key enabling factors for mHealth adoption in developing countries. On the contrary, absence of national policy on mHealth, poor knowledge base on mHealth, using two systems in parallel, duplication of efforts, poor Internet connectivity and shortage of electricity are important inhibiting factors for mHealth adoption.Conclusions
The review provides an insight about the challenges and opportunities related to mHealth adoption in developing countries. Implementation agencies should give careful consideration to these factors before designing and deploying any mHealth-enabled intervention. It is also important to understand the concept of incremental innovation so that resources spent on pilot interventions are optimized and full potential is achieved. 相似文献90.
Ronald T. Toth Samantha E. Pace Brittney J. Mills Sangeeta B. Joshi Reza Esfandiary C. Russell Middaugh David D. Weis David B. Volkin 《Journal of pharmaceutical sciences》2018,107(4):1009-1019
Antibodies are molecules that exhibit diverse conformational changes on different timescales, and there is ongoing interest to better understand the relationship between antibody conformational dynamics and storage stability. Physical stability data for an IgG4 monoclonal antibody (mAb-D) were gathered through traditional forced degradation (temperature and stirring stresses) and accelerated stability studies, in the presence of different additives and solution conditions, as measured by differential scanning calorimetry, size exclusion chromatography, and microflow imaging. The results were correlated with hydrogen exchange mass spectrometry (HX-MS) data gathered for mAb-D in the same formulations. Certain parameters of the HX-MS data, including hydrogen exchange in specific peptide segments in the CH2 domain, were found to correlate with stabilization and destabilization of additives on mAb-D during thermal stress. No such correlations between mAb physical stability and HX-MS readouts were observed under agitation stress. These results demonstrate that HX-MS can be set up as a streamlined methodology (using minimal material and focusing on key peptide segments at key time points) to screen excipients for their ability to physically stabilize mAbs. However, useful correlations between HX-MS and either accelerated or real-time stability studies will be dependent on a particular mAb's degradation pathway(s) and the type of stresses used. 相似文献